Community-acquired pneumonia against a background of chronic heart failure: diagnosis and treatment

Abstract

Community-acquired pneumonia is one of the most common infectious diseases in developed countries. Chronic heart failure is an independent risk factor for unfavorable course and prognosis of community-acquired pneumonia. Objective challenges of clinical, radiological, laboratory and microbiological diagnosis of community-acquired pneumonia in elderly patients with chronic heart failure dictate the need for a greater number of physicians to routinely examine for serum biomarkers of inflammation. Systemic antibiotic therapy for the category of patients is carried out in accordance with the standard guidelines and should be based on certain peculiarities of the etiology, impact of concomitant functional impairment of the organ systems and additional medication therapy on the pharmacokinetics of antimicrobial agents, and take into account the risk of potentiation of adverse reactions as a result of administration of drugs.

Keywords

• внебольничная пневмония
• инфекции нижних дыхательных путей
• хроническая сердечная недостаточность
• диагностика
• лечение
• антибактериальная терапия
• фторхинолоны
• левофлоксацин
• моксифлоксацин
• community-acquired pneumonia
• lower respiratory tract infections
• chronic heart failure
• diagnosis
• treatment
• antibiotic therapy
• fluoroquinolones
• levofloxacin
• moxifloxacin